Monica Lo Russo

Monica Lo Russo

Auto-generated profile, based on publicly available information

Monica Lo Russo

Department of Radiation Oncology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Largo Brambilla 3, 50141, Florence, Italy

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
MNMarcel Nachbar
Marcel Nachbar
DMDavid Mönnich
David Mönnich
SBSimon Boeke
Simon Boeke
CGCihan Gani
Cihan Gani
NWNicola Weidner
Nicola Weidner
CDChiara De-Colle
Chiara De-Colle

1 November 2017 in Oral Oncology
Verified
Journal Article
Closed access
PBPierluigi Bonomo
Pierluigi Bonomo
IDIsacco Desideri
Isacco Desideri
MLMauro Loi
Mauro Loi
MRMonica Lo Russo
Monica Lo Russo
EOEmanuela Olmetto
Emanuela Olmetto
LLLorenzo Livi
Lorenzo Livi

13 October 2019 in BJU International
Verified
Journal Article
Closed access
PDF file
GFGiulio Francolini
Giulio Francolini
BJBarbara Alicja Jereczek‐Fossa
Barbara Alicja Jereczek‐Fossa
VCVanessa Di Cataldo
Vanessa Di Cataldo
GSGabriele Simontacchi
Gabriele Simontacchi
GMGiulia Marvaso
Giulia Marvaso
LLLorenzo Livi
Lorenzo Livi


1 January 2019 in Cancer Treatment and Research Communications
Verified
Journal Article
Closed access
GFG. Francolini
G. Francolini
IDIsacco Desideri
Isacco Desideri
BDB. Detti
B. Detti
VCV. Di Cataldo
V. Di Cataldo
1M1 Masi
1 Masi
LLLorenzo Livi
Lorenzo Livi

1 October 2019 in American Journal of Clinical Oncology
Verified
Journal Article
Closed access
DGDaniela Greto
Daniela Greto
CSCalogero Saieva
Calogero Saieva
MLMauro Loi
Mauro Loi
IDIsacco Desideri
Isacco Desideri
CPCamilla Delli Paoli
Camilla Delli Paoli
LLLorenzo Livi
Lorenzo Livi
Objectives: The aim of this study was to analyze patterns of care in elderly soft tissue sarcoma (STS) patients and their impact on clinical outcome and treatment-related toxicity. Materials and Methods: We retrospectively collected data of >65-year-old patients diagnosed with locally advanced STS between 1991 and 2017 in a single institution. Results: The study included 111 patients: 105 (94.6%) patients underwent surgery, associated with preoperative (n=19, 17.1%) or postoperative radiotherapy (n=72, 64.8%). Anthracycline-based chemotherapy was prescribed in 41.4% of patients (n=46). Acute grade ≥3 postoperative radiotherapy–related radiation dermatitis and all grades of chemotherapy-induced neutropenia were significantly correlated to age >80 years (P=0.02) and >70 years (P=0.045), respectively. The mean follow-up was 4.1 years (range, 0.1 to 17.7). Three-year and 5-year local recurrence–free survival were 80.3% and 75.7%, respectively; neither treatment-related nor patient-related characteristics affected local recurrence. Three-year and 5-year distant relapse–free survival were 59.6% and 44.6%, respectively. On multivariate Cox regression, undifferentiated pleomorphic sarcoma histology and Charlson Comorbidity Index >7 were independent factors associated with distant relapse–free survival (P=0.026 and P=0.0001). Overall survival was 62% and 46.6% at 3 and 5 years, respectively. On multivariate Cox regression, surgery and Charlson Comorbidity Index <7 were independent factors associated with overall survival (P=0.006 and P=0.0001). Conclusions: In this study, elderly STS patients receiving a tailored treatment encompassing surgery, radiotherapy, and/or chemotherapy obtained an improved outcome, although caution is advised because of increased toxicity in relation to age. Comorbidities should be considered to offer the best treatment option to this frail patient population.